Levothyrox : a complaint against X will be filed by an association

ALLILI/SIPA

Published the 08.09.2017 at 18h35

A A

Keywords :

thyroïdeLévothyroxjustice

The case will be settled before the justice. The French Association of patients of the thyroid (AFMT) has announced its intention to file a complaint against X with the pole of public health at the Paris tribunal.

Represented by Marie-Odile Bertella-Geffroy, it should start the process during the week of September 11. In cause, the amendment of the composition of the Levothyrox, a medicine used to treat hormonal deregulations. It would be the source of heavy side effects.

The goal is clear : to obtain satisfactory explanations on the part of the manufacturer, Merck, and health authorities. “These medicines are very sensitive and we cannot, without information, nor long procedure and scientific, change the wording,” said lawyer Marie-Odile Berthella-Geffroy. In fact, a number of patients complained of adverse effects after the replacement of one of the excipients of the Levothyrox.

A study launched

With this complaint, the AFMT is right in step with a patient who has been attacking the Merck. Filed in Mougins (Alpes-Maritimes), she accuses the manufacturer of ” endangering the lives of others. “

The respondent has attempted to defend itself, but without convincing the sick. During a press conference, the minister of Health, Agnes Buzyn, has recognized a situation of “crisis” related to the change in formula of this treatment administered in the thyroid disorder. While refusing to characterize the situation of scandal health.

“These effects are notable but they do not put in danger the life of the people, she said. It is important that patients talk to their doctor, but they do not stop their treatment because then, they would be in danger.” A study of pharmacovigilance has been launched to collect all of the reports. The placing on the market of generic versions of has also been raised.